Press Releases
 
Dyslipidemia Drugs Market - Demand for Drugs for Treating Secondary Dyslipidemia to Spur Demand

Dyslipidemia Drugs Market

, 20 March 2019 -- The dyslipidemia drugs market promises lucrative growth opportunities for pharmaceutical manufacturers due to increasing demand and prescriptions of these medications

The global dyslipidemia market is anticipated to witness a decline of -10.3%. CAGR between 2015 and 2023. The negative growth rate is a result of the expiration of blockbuster drugs that have allowed the introduction of several generic drugs, available at cheaper prices than branded drugs. Owing to this reason, the global market is expected to reach a valuation of US$6.88 bn by 2023 as compared to US$17.85 bn in 2014. However, the market also has several opportunities to gain from and reach a positive growth rate in the near future. For instance, the high prevalence of obesity due to poor dietary habits, lack of exercise, and changing lifestyles are expected to present a wide range growth opportunities for the overall market in the near future.

Report Overview: https://www.transparencymarketresearch.com/dyslipidemia-market.html

The rising cases of diabetes, especially the growing number of type 2 diabetics, have presented the global dyslipidemia market with a lucrative opportunity. Research indicates that diabetics are likely to suffer from lipid abnormalities that will lead to a higher uptake of dyslipidemia drugs in the near future. In a bid to solve the health issues of an exponentially growing patient pool, several companies are investing in intensive research and development in strengthening their pipelines and discovering newer treatment options. Furthermore, commercialization of new classes of drugs will also provide this market a push in the upward direction.

The Europe dyslipidemia drugs market is expected to witness a relatively low decline (at a CAGR of -9.9%) over the forecast period of 2015 and 2023. The losses in this regional market will be mitigated by the high incidence of dyslipidemia here. Furthermore, the ability of patients to afford dyslipidemia drugs and supportive reimbursement policies are also expected to keep losses in this market in check to some degree.

Favorable government policies are also expected to help the Europe dyslipidemia market in the near future. Rising healthcare expenditure by dyslipidemia patients in countries such as Germany, France, and the U.K. are also anticipated to create a lucrative growth for sustained growth of the market in the coming years. By the end of forecast period, the Europe dyslipidemia drugs market will reach US$1,802.8 mn by 2023.

Obtain the Sample Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1535

Amongst the various type of drug classes, the fibric acid and omega-3 fatty acid derivatives segment will witness the least decline at a -1.6% CAGR between 2015 and 2023. A growing number of prescriptions for drugs such as Epanova, Vascespa, and Lovaza will be the primary reason why this segment will be able to mitigate its loss. The government approvals for fibric acid and omega-3 fatty acid derivatives class of drugs have also bolstered the demand for dyslipidemia drugs in recent years. The report suggests that Fenofibrate drugs are the popularly prescribed fibric acid and omega-3 fatty acid derived drugs to patients with dyslipidemia.

However, the future of this segment is on unsteady ground as these major drugs are expected to lose their patents. For instance, fenofibrate-containing drugs such as Trilipix, Antara, Tricor, and others will gradually lose importance to generic drugs.

Some of the leading players identified in this market are AstraZeneca plc., Merck & Co., Inc., Pfizer, Inc., Daiichi Sankyo Company, Limited, and Abbott Laboratories. The companies will continue to hold a strong presence due to their brand value and extensive goodwill in the market. Analysts state that new entrants must establish their foothold in the emerging market to profit from the large patient pool in developing countries of China and India and lower manufacturing costs.

Request for Report Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1535

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
Website: https://www.transparencymarketresearch.com/

# # #


Submitted by hawer on Wednesday, 20 March 2019 at 12:27 AM
Category: Health Care & Medical
 
Related News

Pulmonary Arterial Hypertension Market Is Expected To Drive By Availability Of Several Treatment Opt
Wednesday, 26 Jun 2019

Pain Management Therapeutics Market Is Expected To Drive By Rising Number Of Surgeries
Wednesday, 26 Jun 2019

Organ Preservation Solutions Market Is Expected To Drive By Increasing Technological Developments
Wednesday, 26 Jun 2019

Pulmonary Drug Delivery Devices Market is anticipated to exceed a value of US$28.7 bn by 2019
Wednesday, 26 Jun 2019

Ophthalmic Drugs Market Is Expected To Drive By Increasing Incidences of Eye Disorders
Wednesday, 26 Jun 2019

Related Events

2nd Combination Products Lifecycle Management 2019
Tuesday, 25 Jun 2019

ISAH 2019: 15th International Conference on SubArachnoid Hemorrhage 2019
Tuesday, 25 Jun 2019

Cell Engager Summit, June 25-27, 2019, Boston, MA
Tuesday, 25 Jun 2019

Proteome- Targeted Drug Discovery Summit 2019
Wednesday, 26 Jun 2019

4th Microbiome Movement - Drug Development Summit
Wednesday, 26 Jun 2019

Latest News

Party Enjoyable With Bounce Houses
Wednesday, 26 Jun 2019

LeoList Announces A Change In Ownership
Wednesday, 26 Jun 2019

EastShore Mining Devices Revolutionizing Cryptocurrency Mining
Wednesday, 26 Jun 2019

Pulmonary Arterial Hypertension Market Is Expected To Drive By Availability Of Several Treatment Opt
Wednesday, 26 Jun 2019

Pain Management Therapeutics Market Is Expected To Drive By Rising Number Of Surgeries
Wednesday, 26 Jun 2019

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2019
Today is Wednesday, 26 June 2019

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • 2nd Combination Products Lifecycle Management 2019
  • Transition from IBOR to Risk Free Rates | London, 25 - 26 June 2019
  • Palo Alto Networks: Networking breakfast
  • Women of Silicon Roundabout - Join 6,000+ women in tech this June in London
  • Autonomous Ship Technology Symposium - RAI, The Netherlands

  • Latest Jobs
    Sorry, there are currently no entries posted here.